CN101991713A - Medicament containing raw materials of Pu'er tea and worm grass - Google Patents
Medicament containing raw materials of Pu'er tea and worm grass Download PDFInfo
- Publication number
- CN101991713A CN101991713A CN2010105454638A CN201010545463A CN101991713A CN 101991713 A CN101991713 A CN 101991713A CN 2010105454638 A CN2010105454638 A CN 2010105454638A CN 201010545463 A CN201010545463 A CN 201010545463A CN 101991713 A CN101991713 A CN 101991713A
- Authority
- CN
- China
- Prior art keywords
- folium camelliae
- raw material
- camelliae assamicae
- medicine
- raw materials
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the field of medicine or health care foods, and discloses a medicament containing raw materials of 1-20 parts by weight of Pu'er tea and 0.1-2 parts by weight of worm grass or 0.5-3 parts by weight of fermented cordyceps sinensis powder. 1-30 parts by weight of one or more mistletoe, medlar, chrysanthemum, honeysuckle, honey, sweet-scented osmanthus, American ginseng, the stem of noble dendrobium and dwarf lilyturf root is added into the medicament. Experiments and researches show that the medicament has the functions of better reducing blood fat, improving the immunity, and the like.
Description
Technical field
The present invention relates to medicine or field of health care food, be specifically related to the medicine that a kind of raw material contains Folium camelliae assamicae and Cordyceps.
Background technology
Folium camelliae assamicae is because of the place of production old genus Yunnan Pu Erfu (modern Puer City), so gain the name.The present tea produced of general reference Folium camelliae assamicae district is to be raw material with the big-leaf species in yunnan solar dried green tea of generally acknowledging the Folium camelliae assamicae district, the bulk tea and the compressed tea that are processed into through after fermentation.The profile color and luster is brown red, and endoplasm soup color is red dense bright, the unique CHENXIANG of fragrance, and mellow time of flavour is sweet, and is brown red at the bottom of the leaf.The branch that living tea and ripe tea are arranged is given birth to tea natural fermentation, ripe tea artificial repening." Chen Yuexiang more " is acknowledged as the maximum characteristics that Folium camelliae assamicae is distinguished other teas, and " the blue gas of fragrant old nine land measure of 30 mus virtue, product are Pu'er feelings in thousand to the greatest extent." Folium camelliae assamicae is " antique that can enter the mouth ", is different from other tea and is valued for newly, Folium camelliae assamicae is valued for " old ", tends to along with the time appreciates gradually.In recent years, along with development in science and technology, up to the present, protect aspect such as tooth about Folium camelliae assamicae at blood fat reducing, angiocardiopathy preventing, anticancer and strong tooth and carried out physiology, pharmacological effect research more extensively and profoundly, Folium camelliae assamicae constantly obtains the checking of modern medicine to the immune function of human body resultant effect.
But some problems and the single defective of the mouthfeel of Folium camelliae assamicae own along with the Folium camelliae assamicae fermenting and producing aspect that comes out in recent years make the yunnan puer tea industry meet with unprecedented development bottleneck.Again the emergence and the sustainable development of Folium camelliae assamicae industry must depend on new research and innovation.
Summary of the invention
For these reasons, the applicant is by discovering, with Folium camelliae assamicae, fermented Cordyceps powder or Cordyceps polysaccharide is raw material, one or more that add Herba Visci, Fructus Lycii, Flos Chrysanthemi, Flos Lonicerae, Mel, Flos Osmanthi Fragrantis, Radix Panacis Quinquefolii, Herba Dendrobii, Radix Ophiopogonis are prepared into new product, product of the present invention not only has the mouthfeel of giving off a strong fragrance, and pharmacological experiment study shows that novel product of the present invention has better pharmacological action.
The present invention is achieved through the following technical solutions.
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 1-20 weight portion, Cordyceps polysaccharide 0.1-2 weight portion or fermented Cordyceps powder 0.5-3 weight portion.
Wherein raw material also comprises one or more 1-30 weight portions of Herba Visci, Fructus Lycii, Flos Chrysanthemi, Flos Lonicerae, Mel, Flos Osmanthi Fragrantis, Radix Panacis Quinquefolii, Herba Dendrobii, Radix Ophiopogonis.
The beverage of feedstock production wherein.
The beverage of feedstock production wherein.
The wherein pharmaceutical preparation of feedstock production or food.
Wherein pharmaceutical preparation is powder, granule, pill or unguentum.
Wherein food is powder, granule, pill or unguentum.
Fermented Cordyceps powder of the present invention refer to from natural cordyceps separate and arbitrary strain fermentation and mycelium powder, can use its extract.
Cordyceps polysaccharide of the present invention can be to extract from the natural cs sporophore, or extracts from the artificial culture Cordyceps sporophore, or extracts from the Cordyceps mycelium of fermentation culture or fermentation liquid.
Folium camelliae assamicae of the present invention includes but not limited to large leaf Folium camelliae assamicae (ripe tea) or Pu'er tea or instant Pu'er tea or Pu'er tea paste.
Pharmacological testing
Test 1
The blood fat reducing test
Test 1 group: commercially available Folium camelliae assamicae.
Test 2 groups: medicine of the present invention, wherein raw material is Folium camelliae assamicae 1g, Cordyceps polysaccharide 0.1g.
Test 3 groups: medicine of the present invention, raw material Folium camelliae assamicae 20g wherein, Cordyceps polysaccharide 2g.
Test 4 groups: medicine of the present invention, raw material Folium camelliae assamicae 10g wherein, Cordyceps polysaccharide 1g, Radix Panacis Quinquefolii 5g, Herba Dendrobii 8g, Radix Ophiopogonis 12g.
The brewing method of Folium camelliae assamicae tea: with tea sample 6.0g, the normal saline that 200ml boils brews before the experiment, and tinfoil is obturaged and left standstill 5min, uses filtered through gauze, and uses the filter membrane degerming, obtains the liquid that concentration is 0.03g Folium camelliae assamicae/ml at once.
Test 4 groups of preparation methoies of 2 groups-test: extracting in water, extracting liquid filtering is condensed into the liquid of 0.03g raw material/ml.
Experimental technique: the SD rat is divided at random by body weight: model group, experiment medicine group.Each group was irritated stomach 1.0ml/100g lipomul, and prescription is 30% Adeps Sus domestica, 10% cholesterol, 2% cholate, 0.2% propylthiouracil, 20% Tween 80,20% propylene glycol, 10% sucrose, with distilled water melt into 100ml, continuous 10 days.12 hours socket of the eye venous plexuses of fasting are got blood, detect serum TC, TG, HDL-C and LDL-C content, and divide into groups again by the serum TC level.After adjusting grouping, each is organized rat every morning and gives lipomul by above-mentioned modeling test method, emulsion formulations becomes: 20% Adeps Sus domestica, 5% cholesterol, 2% cholate, 0.2% propylthiouracil, 10% tween, 10% propylene glycol, 5% sucrose distilled water melt into 100ml, point-2 were pressed and were respectively organized dosage 0.1ml/g afternoon 1, gastric infusion, 16 weeks of successive administration.After 16 weeks of administration finish, fasting 12 hours, femoral artery is got blood, and a part of blood is used for hemorheology and detects with 1% anticoagulant heparin (about 4ml).Another part blood separation serum is used for the detection of biochemical indicator.Duration of test claims body weight weekly one time, adjusts dosage by body weight, and measures food ration.16 weeks of administration are detected serum TC, TG level respectively.
Experimental result sees Table 1:
Table 1 different pharmaceutical is to the influence of blood fat
Annotate: compare * P<0.05, * * P<0.01 with matched group; Compare △ P<0.05 for 1 group with medicine.
Test 2
Improve immunity test
Trial drug:
Test 1 group: commercially available Folium camelliae assamicae.
Test 2 groups: medicine of the present invention, wherein raw material is Folium camelliae assamicae 1g, fermented Cordyceps powder 0.5g.
Test 3 groups: medicine of the present invention, wherein raw material is Folium camelliae assamicae 10g, fermented Cordyceps powder 3g.
Test 4 groups: Folium camelliae assamicae 5g, fermented Cordyceps powder 1.5g, Herba Visci 3g, Flos Osmanthi Fragrantis 4g, Radix Ophiopogonis 3g.
The brewing method of Folium camelliae assamicae tea: with tea sample 6.0g, the normal saline that 200ml boils brews before the experiment, and tinfoil is obturaged and left standstill 5min, uses filtered through gauze, and uses the filter membrane degerming, obtains the liquid that concentration is 0.03g Folium camelliae assamicae/ml at once.
Test 4 groups of preparation methoies of 2 groups-test: extracting in water, extracting liquid filtering is condensed into the liquid of 0.03g raw material/ml.
Test method: get mice, random packet is a hypoimmunity in the mice modeling in advance, and not modeling of normal group, modeling successfully begin administration, and matched group gives normal saline 0.2ml/20g.Administration group gastric infusion dosage 0.06ml/g, successive administration 20 days, 24 hours broken end sacrificed by exsanguination mices after the drug withdrawal, under aseptic condition, take out spleen, make splenocyte suspension with RPMI-1640 (containing 10% calf serum), and mouse boosting cell is adjusted to 5 * 106 cells/m1, be added in 96 well culture plates, every hole 100ul, each spleen add double (promptly adds ConA, and does not add ConA).ConA 20ul (concentration is 100ug/ml), RPMI-1640 80ul makes every hole to the 200ul volume, cultivates 72 hours in 5%C0237 ℃ of calorstat, stops cultivating preceding 24 hours, and every hole adds 3H one TdR3.7 * 109 (iucr).With cell harvestor (TITERTEK CELL HARVESTER 550) collecting cell on 49 type glass fiber filter paper, use distilled water, 5% 3 ammonia acetic acid, absolute ethanol washing successively, filter paper is put 60 ℃ of incubator oven dry, be added in the cup that contains the 5ml scintillation solution, participate in radioactivity (cpm) through liquid scintillation instrument (BECKMEN LS 9800) survey, calculate stimulation index (SI) then, that is: SI=adds ConA hole cpm/ and does not add ConA hole cpm.
The influence that table 2 different pharmaceutical transforms the hypoimmunity mouse spleen lymphocyte
Group | Stimulation index |
Normal group | 0.756±0.083** |
Matched group | 0.149±0.079 |
Test 1 group | 0.925±0.147** |
Test 2 groups | 1.856±0.214**△ |
Test 3 groups | 1.847±0.226**△ |
Test 4 groups | 2.037±0.246**△ |
Annotate: compare * * P<0.01, * P<0.05 with matched group; Compare △ P<0.05 for 1 group with medicine.
Conclusion (of pressure testing): above-mentioned experiment shows that medicine of the present invention has better pharmacological action than commercially available Folium camelliae assamicae, prove absolutely that the present invention is with the different material compatible combination after, significant.
Preparation embodiment
Embodiment 1
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 1g, Cordyceps polysaccharide 0.1g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 2
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 20g, Cordyceps polysaccharide 2g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 3
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 10g, Cordyceps polysaccharide 1g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 4
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 1g, fermented Cordyceps powder 0.5g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 5
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 20g, fermented Cordyceps powder 3g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 6
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 12g, fermented Cordyceps powder 0.9g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 7
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 1g, Cordyceps polysaccharide 0.1g, Fructus Lycii 1g.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 8
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 20g, Cordyceps polysaccharide 2g, and Herba Visci, structure Qi, Flos Chrysanthemi, Mel, Radix Panacis Quinquefolii, Radix Ophiopogonis be 30g altogether.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 9
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 10g, Cordyceps polysaccharide 1g, and Fructus Lycii, Flos Chrysanthemi, Mel, Flos Osmanthi Fragrantis, Herba Dendrobii be 16g altogether.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 10
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 1g, fermented Cordyceps powder 0.5g, and Herba Visci, Fructus Lycii be 1g altogether.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 11
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 20g, and fermented Cordyceps powder 3g, Mongolian oak post, Flos Osmanthi Fragrantis, Radix Panacis Quinquefolii, Herba Dendrobii, Radix Ophiopogonis 30g altogether.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Embodiment 6
A kind of raw material contains the medicine of Folium camelliae assamicae, and raw material comprises Folium camelliae assamicae 12g, fermented Cordyceps powder 0.9g,, Flos Lonicerae, Mel, Flos Osmanthi Fragrantis, Radix Panacis Quinquefolii, Herba Dendrobii 22g altogether.
The beverage of above-mentioned raw materials preparation.
Above-mentioned raw materials is prepared as powder, granule, pill or unguentum.
Claims (7)
1. a raw material contains the medicine of Folium camelliae assamicae, it is characterized in that raw material comprises Folium camelliae assamicae 1-20 weight portion, Cordyceps polysaccharide 0.1-2 weight portion or fermented Cordyceps powder 0.5-3 weight portion.
2. a kind of medicine that contains Folium camelliae assamicae according to claim 1, wherein raw material also comprises one or more 1-30 weight portions of Herba Visci, structure Qi, Flos Chrysanthemi, Flos Lonicerae, Mel, Flos Osmanthi Fragrantis, Radix Panacis Quinquefolii, Herba Dendrobii, Radix Ophiopogonis.
3. the medicine that contains Folium camelliae assamicae according to claim 1 or 2 one kind of raw material, the wherein beverage of feedstock production.
4. the medicine that contains Folium camelliae assamicae according to claim 1 or 2 one kind of raw material, the wherein beverage of feedstock production.
5. a kind of raw material according to claim 1 and 2 contains the medicine of Folium camelliae assamicae and Truffe, wherein the pharmaceutical preparation of feedstock production or food.
6. a kind of raw material according to claim 5 contains the medicine of Folium camelliae assamicae and Truffe, and wherein pharmaceutical preparation is powder, granule, pill or unguentum.
7. a kind of raw material according to claim 3 contains the medicine of Folium camelliae assamicae and Truffe, and wherein food is powder, granule, pill or unguentum.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105454638A CN101991713A (en) | 2010-11-16 | 2010-11-16 | Medicament containing raw materials of Pu'er tea and worm grass |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010105454638A CN101991713A (en) | 2010-11-16 | 2010-11-16 | Medicament containing raw materials of Pu'er tea and worm grass |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101991713A true CN101991713A (en) | 2011-03-30 |
Family
ID=43782789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2010105454638A Pending CN101991713A (en) | 2010-11-16 | 2010-11-16 | Medicament containing raw materials of Pu'er tea and worm grass |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101991713A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102524464A (en) * | 2012-02-22 | 2012-07-04 | 红云红河烟草(集团)有限责任公司 | Preparation method of dendrobe health-care Pu' er tea cream |
CN103098918A (en) * | 2012-11-12 | 2013-05-15 | 韦有任 | Jasmine cordyceps puerh tea and preparation method thereof |
CN103891949A (en) * | 2014-03-12 | 2014-07-02 | 贵州芳瑞堂生物科技有限公司 | Health-care dark green tea |
CN106135528A (en) * | 2016-07-22 | 2016-11-23 | 柳州市优联科技开发有限公司 | A kind of Herba Visci health tea |
CN107303002A (en) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | A kind of formula and processing technology of the beautifying face and moistering lotion anti-aging skin care products of the composition containing black tea |
CN107873900A (en) * | 2017-12-31 | 2018-04-06 | 何强 | A kind of instant Pu'er tea and preparation method thereof |
-
2010
- 2010-11-16 CN CN2010105454638A patent/CN101991713A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102524464A (en) * | 2012-02-22 | 2012-07-04 | 红云红河烟草(集团)有限责任公司 | Preparation method of dendrobe health-care Pu' er tea cream |
CN103098918A (en) * | 2012-11-12 | 2013-05-15 | 韦有任 | Jasmine cordyceps puerh tea and preparation method thereof |
CN103891949A (en) * | 2014-03-12 | 2014-07-02 | 贵州芳瑞堂生物科技有限公司 | Health-care dark green tea |
CN107303002A (en) * | 2016-04-22 | 2017-10-31 | 长沙星工场生物科技有限公司 | A kind of formula and processing technology of the beautifying face and moistering lotion anti-aging skin care products of the composition containing black tea |
CN106135528A (en) * | 2016-07-22 | 2016-11-23 | 柳州市优联科技开发有限公司 | A kind of Herba Visci health tea |
CN107873900A (en) * | 2017-12-31 | 2018-04-06 | 何强 | A kind of instant Pu'er tea and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102058728B (en) | Medicament with raw materials containing red tea and truffle | |
CN101991713A (en) | Medicament containing raw materials of Pu'er tea and worm grass | |
CN102293273A (en) | Health tea capable of adjusting blood pressure, blood sugar and blood fat and preventing thrombus and apoplexy | |
CN103301290B (en) | Compound longan polysaccharide immune foundation-strengthening prescription and preparation method thereof | |
CN101524389A (en) | Use of Brassica rapa polysaccharide in preparation of anti-hypoxia drugs | |
CN102090474A (en) | Pu'er tea | |
CN102228252A (en) | Application of Chinese medicinal composition in preparation of healthcare foods and medicines for improving hypoxia tolerance | |
CN109692194A (en) | A kind of compound traditional Chinese medicine composite and its preparation method and application for treating diabetic nephropathy | |
CN1558768A (en) | A pharmaceutical composition made from Chinese traditional medicine and preparation method thereof | |
CN116785345A (en) | Astragalus mongholicus strengthening tea with immunity regulating function and preparation method thereof | |
CN102250709B (en) | Beverage prepared from raw material containing truffle | |
CN102133247A (en) | Costustoot extractive with blood sugar reduction activity and application thereof | |
CN108685952A (en) | The new application of cicada fungus | |
CN105687480A (en) | Immunoregulatory traditional Chinese medicine composition and preparation | |
CN111700926B (en) | Millettia speciosa champ extract, preparation method thereof and application thereof in medicines for reducing blood fat and losing weight | |
CN102784215B (en) | Snow pear cough-relieving syrup and preparation method | |
CN108065393A (en) | A kind of food or health food prevented and treat cardiovascular and cerebrovascular disease | |
CN102846720B (en) | Composite for lowering blood fat and improving anoxia endurance | |
CN112754014A (en) | Composition for preventing and treating cardiovascular and cerebrovascular diseases and preparation method thereof | |
CN1803163A (en) | Chinese medicine for treating AIDS | |
CN101658564B (en) | Medicinal plant for treating diabetes mellitus | |
CN102228246B (en) | Method for preparing sweet ganoderma lucidum preparation | |
CN108686126A (en) | A kind of liver-protecting and alcoholism-relieving prescription and preparation and application | |
CN102488742A (en) | Preparation method of astragaloside | |
CN109497511A (en) | A kind of fungal extract composition and its preparing the application in functional food and health care product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110330 |